Zevra Therapeutics Inc (ZVRA)
9.13
+0.16
(+1.78%)
USD |
NASDAQ |
Nov 21, 16:00
9.145
+0.02
(+0.16%)
After-Hours: 20:00
Zevra Therapeutics Market Cap: 487.32M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 487.32M |
| November 20, 2024 | 478.78M |
| November 19, 2024 | 478.78M |
| November 18, 2024 | 459.03M |
| November 15, 2024 | 460.10M |
| November 14, 2024 | 481.98M |
| November 13, 2024 | 462.24M |
| November 12, 2024 | 457.43M |
| November 11, 2024 | 478.25M |
| November 08, 2024 | 480.38M |
| November 07, 2024 | 468.93M |
| November 06, 2024 | 468.93M |
| November 05, 2024 | 458.29M |
| November 04, 2024 | 455.09M |
| November 01, 2024 | 447.11M |
| October 31, 2024 | 433.80M |
| October 30, 2024 | 448.71M |
| October 29, 2024 | 439.66M |
| October 28, 2024 | 428.48M |
| October 25, 2024 | 412.51M |
| October 24, 2024 | 420.50M |
| October 23, 2024 | 426.35M |
| October 22, 2024 | 443.92M |
| October 21, 2024 | 454.56M |
| October 18, 2024 | 451.90M |
| Date | Value |
|---|---|
| October 17, 2024 | 454.03M |
| October 16, 2024 | 450.30M |
| October 15, 2024 | 446.05M |
| October 14, 2024 | 430.08M |
| October 11, 2024 | 434.34M |
| October 10, 2024 | 421.56M |
| October 09, 2024 | 450.84M |
| October 08, 2024 | 445.51M |
| October 07, 2024 | 414.64M |
| October 04, 2024 | 383.24M |
| October 03, 2024 | 382.17M |
| October 02, 2024 | 378.98M |
| October 01, 2024 | 364.61M |
| September 30, 2024 | 369.40M |
| September 27, 2024 | 364.12M |
| September 26, 2024 | 384.64M |
| September 25, 2024 | 397.00M |
| September 24, 2024 | 435.15M |
| September 23, 2024 | 398.84M |
| September 20, 2024 | 424.10M |
| September 19, 2024 | 421.99M |
| September 18, 2024 | 412.00M |
| September 17, 2024 | 396.21M |
| September 16, 2024 | 409.37M |
| September 13, 2024 | 413.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.387M
Minimum
Mar 18 2020
487.32M
Maximum
Nov 21 2024
189.87M
Average
188.33M
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals Inc | 5.359B |
| Vanda Pharmaceuticals Inc | 288.04M |
| BioCardia Inc | 9.788M |
| Xeris Biopharma Holdings Inc | 453.21M |
| Instil Bio Inc | 161.58M |
Market Cap Related Metrics
| PS Ratio | 15.86 |
| PEG Ratio | -0.0172 |
| Price to Book Value | 6.985 |
| Price | 9.13 |
| Earnings Yield | -23.11% |
| PEGY Ratio | -0.0172 |